Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Change in Cash (2016 - 2025)

Historic Change in Cash for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to -$2.0 million.

  • Sanara MedTech's Change in Cash fell 11993.81% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 million, marking a year-over-year decrease of 11332.04%. This contributed to the annual value of $10.7 million for FY2024, which is 38152.42% up from last year.
  • Per Sanara MedTech's latest filing, its Change in Cash stood at -$2.0 million for Q3 2025, which was down 11993.81% from -$3.7 million recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Change in Cash ranged from a high of $26.9 million in Q1 2021 and a low of -$3.7 million during Q2 2025
  • Over the past 5 years, Sanara MedTech's median Change in Cash value was -$1.7 million (recorded in 2023), while the average stood at $762330.5.
  • As far as peak fluctuations go, Sanara MedTech's Change in Cash tumbled by 30989.11% in 2021, and later surged by 566422.1% in 2024.
  • Sanara MedTech's Change in Cash (Quarter) stood at -$3.7 million in 2021, then surged by 64.33% to -$1.3 million in 2022, then grew by 17.92% to -$1.1 million in 2023, then surged by 63.36% to -$398894.0 in 2024, then tumbled by 406.17% to -$2.0 million in 2025.
  • Its last three reported values are -$2.0 million in Q3 2025, -$3.7 million for Q2 2025, and $4.8 million during Q1 2025.